Oregon College of Oriental Medicine Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2002
NCT00034047
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

nafarelin (synarel) (1 trial)

Drugs in Phase 1 Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometriosis (Phase 2)

Pelvic Pain (Phase 2)

Vulvar Vestibulitis (Phase 1)

Vulvodynia (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2